Delivery Order SPE2DB22D6029-SPE2DB24FU0TM
Award Date 4/23/24
Potential Completion Date 4/24/24
Potential Value $8.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $26,903.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product, with a period of performance ending on March 10, 2025. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC,...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $19,106.07, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $97,323.89 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a July 2024 completion date and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $13,675.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product, and has a completion date of February 24, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award, valued at $37,024.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TREMFYA 100 MG/ML INJECTORML, a medical product, with an ultimate completion date of April 2, 2025. The contract type is Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
- This federal contract award, valued at $8,250.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of the drug product TREMFYA 100 MG/ML INJECTORML, with a delivery completion date of May 8, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,274.20, is for the delivery of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 11, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp is...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $21,217.81 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 1, 2024 with a completion date of March 4, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,825.97 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical for...
- This federal contract award is for the delivery of the pharmaceutical product TREMFYA 100 MG/ML SYRINGEML, valued at $8,266.87, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical distributor Amerisourcebergen Corporation. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 1, 2024. It is not designated as a set-aside contract....